Concepedia

Sammy Metobo

SM

Statistics

Publications

10

Citations

432

H-Index

10

Active since

2003

Affiliations

Gilead Sciences (United States)(Current)

Sammy Metobo is an author at Gilead Sciences (United States) specializing in medicinal chemistry, drug discovery, and drug design.

Publications per year

2003–2025

10

Publications

10

Discovery of the First <i>C</i>-Nucleoside HCV Polymerase Inhibitor (GS-6620) with Demonstrated Antiviral Response in HCV Infected Patients

Aesop Cho, Lijun Zhang, Jie Xu et al. · Journal of Medicinal Chemistry · 2013 · 128 citations

, , +17

Discovery of GS-9688 (Selgantolimod) as a Potent and Selective Oral Toll-Like Receptor 8 Agonist for the Treatment of Chronic Hepatitis B

Richard L. Mackman, Michael Mish, Gregory Chin et al. · Journal of Medicinal Chemistry · 2020 · 77 citations · Full text

, , +14

Synthetic Studies on Ecteinascidin-743:  Constructing a Versatile Pentacyclic Intermediate for the Synthesis of Ecteinascidins and Saframycins

Wei Jin, Sammy Metobo, Robert M. Williams · Organic Letters · 2003 · 51 citations

, , +15

Practical synthesis of 1′-substituted Tubercidin C-nucleoside analogs

Sammy Metobo, Jie Xu, Oliver L. Saunders et al. · Tetrahedron Letters · 2011 · 50 citations

, , +11

Design, synthesis, and biological evaluation of novel tricyclic HIV-1 integrase inhibitors by modification of its pyridine ring

Sammy Metobo, Haolun Jin, Manuel Tsiang et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 45 citations · Full text

, , +16

1–5 of 10